Join Host Grant Stevens, MD, and Mark Foley for the First Episode of the Aesthetics Innovators Podcast
Share This Episode
Welcome to the Aesthetics Innovators Podcast. In this episode, host Grant Stevens, MD, the founder and medical director of Marina Plastic Surgery and The Orange Twist Institute, discusses the future of aesthetics innovation with Mark Foley, the former CEO of Zeltiq. Dr. Stevens, Foley, and Josh Makower, MD, general partner at NEA, serve as co-chairs of the Aesthetics Innovation Summit, which will take place on May 15 in New Orleans prior to the ASAP’s annual meeting.
W. Grant Stevens, MD, FACS
CEO / Chief Medical Officer & Co-Founder / Clinical Professor
Marina Plastic Surgery / OrangeTwist Institute / USC School of Medicine
Dr. Grant Stevens is the founder and Medical Director of Marina Plastic Surgery and The OrangeTwist Institute; a medical spa in Marina Del Rey, California. He is also a Clinical Professor of Plastic Surgery at the University of Southern California; Chairman of the USC-Marina Aesthetic Surgery Fellowship and the Director of the USC Division of Aesthetic Surgery.
Dr. Stevens is on the board of directors of the American Society for Aesthetic Plastic Surgery, serving as president elect. He is also third vice president and on the board of directors of the International Society of Aesthetic Plastic Surgery (ISAPS).
He is a board-certified Diplomate of the American Board of Plastic Surgery, a Fellow of the American College of Surgeons and the International College of Surgeons. Dr. Stevens is an ASAPS and ISAPS Traveling Professor and has been an invited visiting professor at numerous U.S. and international universities.
Dr. Stevens has authored more than 90 articles and chapters on aesthetic plastic surgery. He has also lectured at numerous international, national and regional meetings. Dr. Stevens is a member of many medical societies, including the American Society for Aesthetic Plastic Surgery, International Society of Aesthetic Plastic Surgery, American Society of Plastic Surgeons, International College of Surgeons, American College of Surgeons, and American Society for Laser Medicine & Surgery.
Since joining RWI Ventures in 2004, Mark has led the firm’s healthcare investments. Representative investments where Mark led the financing and joined the Board of Directors include BaroSense (where he was the lead Series B investor), Sonitus Medical (where he was the sole Series A investor) and Voyage Medical (where he was also the sole Series A investor).
Co-investors investing in the same or later rounds of Mark’s portfolio companies include: Kleiner Perkins, Three Arch Partners, Novartis, Aberdare Ventures, Delphi Ventures, Frazier Healthcare, Abbott, Foundation Capital, Bessemer Venture Partners, along with others.
Additionally, Mark serves as Executive Chairman/Board Member for Zeltiq Aesthetics and Onpharma (formerly Monterey Devices).
Prior to RWI Ventures, Mark spent 17 years in senior operating roles at both large and small start-up medical device companies, most recently founding and serving as CEO of cardiac device maker, Ventrica, which was acquired by Medtronic in 2004. Before Ventrica, Mark worked for leading device companies Perclose (acquired by Abbott), Guidant, DVI (acquired by Eli Lilly), US Surgical Corporation (acquired by Tyco) and American Cyanamid.
Because of the breadth of his operating experience, Mark has an intimate understanding of all aspects of what it takes to make a start-up company successful, as well as an extensive rolodex and strong personal relationships with many key influencers in the Bay Area.
Mark received his B.A. from the University of Notre Dame and is a named inventor on 13 patents.